IUCPQ

Running trials

• Not yet recruiting

  A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk

  NCT07900633· Phase 3· Source

• Recruiting

  A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

  NCT07361497· Phase 3· Source

• Recruiting

  A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

  NCT07219173· Phase 2· Source

• Not yet recruiting

  Digital Preparation for Bariatric Surgery: Feasability Pilot Trial

  NCT07201870· Source

• Recruiting

  Restrospective Analysis of MACE in Patients Treated With Drug-elluting Balloons.

  NCT06972225· Source

• Recruiting

  Medical Treatment With or Without Transcatheter Patent Foramen Ovale Closure

  NCT05907694· Source

• Recruiting

  Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR

  NCT05459233· Source

• Recruiting

  BariaPSY: the Data Bank

  NCT05602805· Source

• Recruiting

  Discontinuation of Antithrombotic Treatment Following Patent Foramen Ovale Closure in Young Patients With Cryptogenic Stroke

  NCT04475510· Source

• Active, not recruiting

  Comparison of the Balloon-Expandable Edwards Valve and Self-Expandable CoreValve Evolut R or Evolut PRO System for the Treatment of Small, Severely Dysfunctional Surgical Aortic Bioprotheses. The 'LYTEN' Trial

  NCT03520101· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity3 recruiting
• Stroke2 recruiting
• Asthma1 recruiting
• Coronary artery disease1 recruiting
• Lung cancer1 recruiting
• Type 2 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Study of the Characteristics of Orthorexia Nervosa in the Population Living with Type 1 Diabetes

  NCT05546281· Source

• Completed

  Canadian EdoxAban(Lixiana®) Registry in Patients With ATrial Fibrillation/Flutter With Confirmed ValvUlar HeaRt DiseasE

  NCT03488420· Source